Complications after elective percutaneous coronary interventions: A comparison between public and private hospitals

被引:8
作者
Ferreira, Roberto Muniz [1 ,2 ]
de Souza e Silva, Nelson Albuquerque [1 ]
Alvares Salis, Lucia Helena [1 ]
机构
[1] Univ Fed Rio de Janeiro, Edson Saad Heart Inst, Rua Rodolpho Paulo Rocco 255, BR-21941913 Rio De Janeiro, RJ, Brazil
[2] Samaritano Hosp, Cardiol Dept, Rua Bambina 98, BR-22251050 Rio De Janeiro, RJ, Brazil
关键词
Coronary disease; Cardiac catheterization; Complications;
D O I
10.1016/j.ihj.2017.06.012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Complications after percutaneous coronary interventions (PCI) are associated with significant morbidity and mortality, although institutional discrepancies can occur when public and private hospitals coexist within the healthcare system. The aim of this study was to compare the in-hospital complication rates and mortality in addition to long-term survival following elective PCI in two reference public and private cardiology hospitals in Rio de Janeiro, Brazil. Methods: From January 1st 2013 to December 31st 2014, a total of 440 procedures were identified in both hospitals (public: 328 vs. private: 112) and retrospectively analyzed by chart review. Results: There were no significant differences between the two hospitals regarding the total number of procedures with at least one complication (public: 23.8 vs. private: 17.9%, p = 0.2) or in-hospital mortality rates (public: 0.6% vs. private: 0%, p = 0.5). Post-procedural renal insufficiency was more frequent in the private hospital, whereas coronary-related complications were more prevalent in the public hospital. After a mean follow up of 30.3 months (SD +/- 9.2), the survival rate was also similar. Conclusions: Clinical complications after elective PCI are common both in public and private hospitals. Meticulous pre-procedural clinical assessment and patient selection as well as adherence to guideline-based practices could minimize the risk of PCI-related adverse events. (C) 2017 Published by Elsevier B.V. on behalf of Cardiological Society of India.
引用
收藏
页码:32 / 36
页数:5
相关论文
共 10 条
  • [1] Reporting of harm in randomized controlled trials evaluating stents for percutaneous coronary intervention
    Ethgen, Morgane
    Boutron, Isabelle
    Steg, Philippe Gabriel
    Roy, Carine
    Ravaud, Philippe
    [J]. TRIALS, 2009, 10
  • [2] Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease A Meta-Analysis of Randomized Trials
    Ferrante, Giuseppe
    Rao, Sunil V.
    Juni, Peter
    Da Costa, Bruno R.
    Reimers, Bernhard
    Condorelli, Gianluigi
    Anzuini, Angelo
    Jolly, Sanjit S.
    Bertrand, Olivier F.
    Krucoff, Mitchell W.
    Windecker, Stephan
    Valgimigli, Marco
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (14) : 1419 - 1434
  • [3] Ganassin Fabio Peixoto, 2012, Rev. Bras. Cardiol. Invasiva, V20, P386, DOI 10.1590/S2179-83972012000400008
  • [4] Kaul U, 2010, INDIAN J MED RES, V132, P543
  • [5] Prognostic Impact of Periprocedural Bleeding and Myocardial Infarction After Percutaneous Coronary Intervention in Unselected Patients Results From the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry
    Lindsey, Jason B.
    Marso, Steven P.
    Pencina, Michael
    Stolker, Joshua M.
    Kennedy, Kevin F.
    Rihal, Charanjit
    Barsness, Greg
    Piana, Robert N.
    Goldberg, Steven L.
    Cutlip, Donald E.
    Kleiman, Neal S.
    Cohen, David J.
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (11) : 1074 - 1082
  • [6] Percutaneous Coronary Intervention in Brazil. Results from the Brazilian Public Health System
    Piegas, Leopoldo Soares
    Haddad, Nagib
    [J]. ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2011, 96 (04) : 317 - 324
  • [7] Grade of chronic renal failure, and acute and long-term outcome after percutaneous coronary interventions
    Reinecke, H
    Trey, T
    Matzkies, F
    Fobker, M
    Breithardt, G
    Schaefer, RM
    [J]. KIDNEY INTERNATIONAL, 2003, 63 (02) : 696 - 701
  • [8] Mallet ALR, 2009, REV SAUDE PUBL, V43
  • [9] Third Universal Definition of Myocardial Infarction
    Thygesen, Kristian
    Alpert, Joseph S.
    Jaffe, Allan S.
    Simoons, Maarten L.
    Chaitman, Bernard R.
    White, Harvey D.
    Katus, Hugo A.
    Apple, Fred S.
    Lindahl, Bertil
    Morrow, David A.
    Clemmensen, Peter M.
    Johanson, Per
    Hod, Hanoch
    Underwood, Richard
    Bax, Jeroen J.
    Bonow, Robert O.
    Pinto, Fausto
    Gibbons, Raymond J.
    Fox, Keith A.
    Atar, Dan
    Newby, L. Kristin
    Galvani, Marcello
    Hamm, Christian W.
    Uretsky, Barry F.
    Steg, Gabriel
    Wijns, William
    Bassand, Jean-Pierre
    Menasche, Phillippe
    Ravkilde, Jan
    Ohman, E. Magnus
    Antman, Elliott M.
    Wallentin, Lars C.
    Armstrong, Paul W.
    Januzzi, James L.
    Nieminen, Markku S.
    Gheorghiade, Mihai
    Filippatos, Gerasimos
    Luepker, Russell V.
    Fortmann, Stephen P.
    Rosamond, Wayne D.
    Levy, Dan
    Wood, David
    Smith, Sidney C.
    Hu, Dayi
    Lopez-Sendon, Jose-Luis
    Robertson, Rose Marie
    Weaver, Douglas
    Tendera, Michal
    Bove, Alfred A.
    Parkhomenko, Alexander N.
    [J]. CIRCULATION, 2012, 126 (16) : 2020 - +
  • [10] Type 4a Myocardial Infarction: Incidence, Risk Factors, and Long-Term Outcomes
    Yang, Xiaoyu
    Tamez, Hector
    Lai, Carol
    Ho, Kalon
    Cutlip, Donald
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2017, 89 (05) : 849 - 856